BREAKING
Home » Posts Tagged "Novartis"

Novartis and Medicines for Malaria Venture report positive results for Phase 2b study of novel ganaplacide/lumefantrine combination in children with malaria

By

NewsDesk  @infectiousdiseasenews As the threat of resistance to current malaria treatment grows, Novartis and MMV have reported positive results of a new non-artemisinin combination in a Phase 2b study. The...

SARS-CoV-2

Hydroxychloroquine: Novartis reaches agreement with FDA to proceed with a Phase III clinical trial in hospitalized COVID-19 patients

By

Novartis has reached an agreement with the US Food and Drug Administration (FDA) to proceed with a Phase III clinical trial with approximately 440 patients to evaluate the use of hydroxychloroquine for...

Visceral leishmaniasis: Novartis and DNDi to jointly develop a new oral drug

By

Novartis and the Drugs for Neglected Diseases initiative (DNDi), a not-for-profit research and development (R&D) organization, have signed a collaboration and licence agreement to jointly develop LXE408,...

MS drug, Mayzent, receives FDA approval

By

The U.S. Food and Drug Administration today approved Mayzent (siponimod) tablets to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting...

Fascioliasis drug, Egaten receives FDA approval

By

Novartis announced this week the approval of Egaten® (triclabendazole) by the US Food and Drug Administration (FDA) for the treatment of fascioliasis in patients six years of age and older. Egaten is...

Cryptosporidium: Novartis and the Bill & Melinda Gates Foundation form alliance to develop drug candidate

By

Novartis and the Bill & Melinda Gates Foundation have formed an alliance to advance development of Novartis’ drug candidate KDU731 for the treatment of cryptosporidiosis. Diarrheal diseases are...

Cryptosporidium: Discovery and early validation of a drug candidate progresses

By

Infectious disease scientists from Novartis, the University of Georgia and Washington State University have reported the discovery and early validation of a drug candidate for treating cryptosporidiosis,...

Acute myeloid leukemia (AML) drug, Rydapt, receives FDA approval

By

The U.S. Food and Drug Administration today approved Rydapt (midostaurin) for the treatment of adult patients with newly diagnosed acute myeloid leukemia (AML) who have a specific genetic mutation called...

Chagas, leishmaniasis and sleeping sickness cured with one drug? Researchers get a little closer

By

Scientists say they are a step closer to providing effective treatments for three “neglected” diseases after making a chemical which can kill the parasites that cause the illnesses. Chagas disease,...

TB drug, Onecure, recalled in Philippines due to ‘insufficient amount of Rifampicin’

By

The Philippines Food and Drug Administration (FDA) announced the recall of the anti-tuberculosis drug, Onecure, after one component of the drug failed specifications. Onecure, which is manufactured by...